120 related articles for article (PubMed ID: 36444968)
1. Long non-coding RNA TDRG1 aggravates lung cancer stemness by binding to Sox2 mRNA.
Lu Y; Cheng J; Mao Q; Wang Z; Wei Q
Environ Toxicol; 2023 Mar; 38(3):645-653. PubMed ID: 36444968
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA TDRG1 aggravates colorectal cancer stemness by binding with miR-873-5p to upregulate PRKAR2.
Hong Q; Mai P; Wu B; Wang H; Xiao M; You J
Environ Toxicol; 2022 Oct; 37(10):2366-2374. PubMed ID: 35730470
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA
Zhao X; Wu J; Li Y; Ye F; Wang C
Bioengineered; 2021 Dec; 12(1):8698-8708. PubMed ID: 34697986
[TBL] [Abstract][Full Text] [Related]
4. LncRNA MALAT1 increases the stemness of gastric cancer cells via enhancing SOX2 mRNA stability.
Xiao Y; Pan J; Geng Q; Wang G
FEBS Open Bio; 2019 Jul; 9(7):1212-1222. PubMed ID: 31037832
[TBL] [Abstract][Full Text] [Related]
5. Long Non-Coding RNA HOTAIR Regulates the Proliferation, Self-Renewal Capacity, Tumor Formation and Migration of the Cancer Stem-Like Cell (CSC) Subpopulation Enriched from Breast Cancer Cells.
Deng J; Yang M; Jiang R; An N; Wang X; Liu B
PLoS One; 2017; 12(1):e0170860. PubMed ID: 28122024
[TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA OIP5-AS1 promotes the stemness of lung cancer cells through enhancing Oct4 mRNA stability.
Mao C; Li X
Environ Toxicol; 2022 May; 37(5):1104-1112. PubMed ID: 35044041
[TBL] [Abstract][Full Text] [Related]
7. CDK1 promotes the stemness of lung cancer cells through interacting with Sox2.
Huang Z; Shen G; Gao J
Clin Transl Oncol; 2021 Sep; 23(9):1743-1751. PubMed ID: 33721187
[TBL] [Abstract][Full Text] [Related]
8. LncRNA TDRG1 enhances tumorigenicity in endometrial carcinoma by binding and targeting VEGF-A protein.
Chen S; Wang LL; Sun KX; Liu Y; Guan X; Zong ZH; Zhao Y
Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):3013-3021. PubMed ID: 29920344
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA TDRG1 promotes hypoxia-induced glycolysis by targeting the miR-214-5p/SEMA4C axis in cervical cancer cells.
Li X; Zhang C; Tian Y
J Mol Histol; 2021 Apr; 52(2):245-256. PubMed ID: 33394293
[TBL] [Abstract][Full Text] [Related]
10. LncRNA TDRG1 promotes the metastasis of NSCLC cell through regulating miR-873-5p/ZEB1 axis.
Hu X; Mu Y; Wang J; Zhao Y
J Cell Biochem; 2021 Sep; 122(9):969-982. PubMed ID: 31742752
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of long non-coding RNA linc-ITGB1 inhibits cancer stemness and epithelial-mesenchymal transition by reducing the expression of Snail in non-small cell lung cancer.
Guo L; Sun C; Xu S; Xu Y; Dong Q; Zhang L; Li W; Wang X; Ying G; Guo F
Thorac Cancer; 2019 Feb; 10(2):128-136. PubMed ID: 30485693
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA FENDRR attenuates the stemness of non-small cell lung cancer cells via decreasing multidrug resistance gene 1 (MDR1) expression through competitively binding with RNA binding protein HuR.
Gong F; Dong D; Zhang T; Xu W
Eur J Pharmacol; 2019 Jun; 853():345-352. PubMed ID: 30981768
[TBL] [Abstract][Full Text] [Related]
13. LncRNA DGCR5 contributes to CSC-like properties via modulating miR-330-5p/CD44 in NSCLC.
Wang R; Dong HX; Zeng J; Pan J; Jin XY
J Cell Physiol; 2018 Sep; 233(9):7447-7456. PubMed ID: 29663359
[TBL] [Abstract][Full Text] [Related]
14. SOX2-induced upregulation of lncRNA LINC01561 promotes non-small-cell lung carcinoma progression by sponging miR-760 to modulate SHCBP1 expression.
Gao W; Qi CQ; Feng MG; Yang P; Liu L; Sun SH
J Cell Physiol; 2020 Oct; 235(10):6684-6696. PubMed ID: 32003010
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA TDRG1 aggravates doxorubicin-induced cardiomyopathy by binding with miR-873-5p to upregulate PRKAR2.
Liu Y; Tan L; Zhang M; Yang C
Environ Toxicol; 2022 Aug; 37(8):2072-2083. PubMed ID: 35524977
[TBL] [Abstract][Full Text] [Related]
16. LncRNA
Wu H; He Y; Chen H; Liu Y; Wei B; Chen G; Lin H; Lin H
FEBS Open Bio; 2019 Apr; 9(4):781-790. PubMed ID: 30984551
[TBL] [Abstract][Full Text] [Related]
17. Nuclear reprogramming of luminal-like breast cancer cells generates Sox2-overexpressing cancer stem-like cellular states harboring transcriptional activation of the mTOR pathway.
Corominas-Faja B; Cufí S; Oliveras-Ferraros C; Cuyàs E; López-Bonet E; Lupu R; Alarcón T; Vellon L; Iglesias JM; Leis O; Martín ÁG; Vazquez-Martin A; Menendez JA
Cell Cycle; 2013 Sep; 12(18):3109-24. PubMed ID: 23974095
[TBL] [Abstract][Full Text] [Related]
18. A non-metabolic function of hexokinase 2 in small cell lung cancer: promotes cancer cell stemness by increasing USP11-mediated CD133 stability.
Wang J; Shao F; Yang Y; Wang W; Yang X; Li R; Cheng H; Sun S; Feng X; Gao Y; He J; Lu Z
Cancer Commun (Lond); 2022 Oct; 42(10):1008-1027. PubMed ID: 35975322
[TBL] [Abstract][Full Text] [Related]
19. LncRNA TDRG1 promotes the proliferation, migration, and invasion of cervical cancer cells by sponging miR-214-5p to target SOX4.
Guo M; Lin B; Li G; Lin J; Jiang X
J Recept Signal Transduct Res; 2020 Jun; 40(3):281-293. PubMed ID: 32106739
[TBL] [Abstract][Full Text] [Related]
20. LncRNA TDRG1 functions as an oncogene in cervical cancer through sponging miR-330-5p to modulate ELK1 expression.
Zhao H; Hu GM; Wang WL; Wang ZH; Fang Y; Liu YL
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7295-7306. PubMed ID: 31539116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
